Duong Eric, Xiao Jiening, Qi Xiao Yan, Nattel Stanley
Department of Pharmacology and Therapeutics, McGill University, Montreal, Canada; Department of Medicine, Montreal Heart Institute and Université de Montréal, Montreal, Canada.
Department of Medicine, Montreal Heart Institute and Université de Montréal, Montreal, Canada.
Heart Rhythm. 2017 May;14(5):739-748. doi: 10.1016/j.hrthm.2017.01.045. Epub 2017 Feb 8.
Complete atrioventricular block (CAVB) causes arrhythmogenic remodeling and increases the risk of torsades de pointes arrhythmias. MicroRNAs (miRNAs) are key regulators of gene expression that contribute to cardiac remodeling.
The purpose of this study was to assess miRNA changes after CAVB and identify novel candidates potentially involved in arrhythmogenic cardiac remodeling.
CAVB was induced in mice via His-bundle ablation. Expression of miRNAs was evaluated by pan-miRNA microarray with quantitative polymerase chain reaction (qPCR) confirmation, on samples obtained 24 hours and 4 weeks post-CAVB. MiRNA target prediction algorithms were used to identify potential target genes. Targets confirmed by luciferase assays in HEK293 cells were followed up with overexpression studies in neonatal rat ventricular myocytes to evaluate regulation using real time- quantitative polymerase chain reaction (RT-qPCR), western blots, cell shortening measurements, and fura-2 Ca fluorescence imaging.
Of >400 miRNAs assayed, only miRNA-135a (miR-135a) was altered at 24 hours, down-regulated 78% (P <.001). Algorithms predicted miR-135a regulation of the sodium-calcium exchanger type 1 (NCX1). miR-135a transfection suppressed NCX1 3'UTR reporter activity by 42% (P <.001), mRNA expression by 34% (P <.001), and protein levels by 45% (P <.001) vs noncoding miRNA control. miR-135a overexpression reduced spontaneous beating frequency of neonatal rat ventricular myocytes by 63% (P <.001) while slowing decay (by 56%, P <.05) of caffeine-induced Ca transients. miR-135a also suppressed the Ca loading effects of ouabain and ouabain-induced spontaneous Ca release events.
NCX1 is negatively regulated by miR-135a, a microRNA that is down-regulated in the heart after CAVB in mice. By controlling NCX1 expression, miR-135a modulates cardiomyocyte automaticity, Ca extrusion, and arrhythmogenic Ca loading/spontaneous Ca release events. Therefore, miR-135a may contribute to proarrhythmic remodeling after CAVB.
完全性房室传导阻滞(CAVB)可导致致心律失常性重塑,并增加尖端扭转型室性心律失常的风险。微小RNA(miRNA)是基因表达的关键调节因子,参与心脏重塑过程。
本研究旨在评估CAVB后miRNA的变化,并确定可能参与致心律失常性心脏重塑的新候选miRNA。
通过希氏束消融在小鼠中诱导CAVB。在CAVB后24小时和4周获取的样本上,采用全miRNA微阵列结合定量聚合酶链反应(qPCR)进行miRNA表达评估。使用miRNA靶标预测算法识别潜在的靶基因。在HEK293细胞中通过荧光素酶测定法确认的靶标,随后在新生大鼠心室肌细胞中进行过表达研究,以使用实时定量聚合酶链反应(RT-qPCR)、蛋白质免疫印迹、细胞缩短测量和fura-2钙荧光成像来评估调节作用。
在检测的400多种miRNA中,只有miRNA-135a(miR-135a)在24小时时发生改变,下调了78%(P<.001)。算法预测miR-135a对1型钠钙交换体(NCX1)有调节作用。与非编码miRNA对照相比,miR-135a转染使NCX1 3'UTR报告基因活性降低42%(P<.001),mRNA表达降低34%(P<.001),蛋白质水平降低45%(P<.001)。miR-135a过表达使新生大鼠心室肌细胞的自发搏动频率降低63%(P<.001),同时减缓咖啡因诱导的钙瞬变的衰减(降低56%,P<.05)。miR-135a还抑制了哇巴因的钙加载效应和哇巴因诱导的自发钙释放事件。
NCX1受miR-135a负调控,miR-135a是一种在小鼠CAVB后心脏中下调的微小RNA。通过控制NCX1的表达,miR-135a调节心肌细胞的自律性钙外流以及致心律失常性钙加载/自发钙释放事件。因此,miR-135a可能在CAVB后的促心律失常重塑中起作用。